Calmodulin inhibitors chlorpromazine and calmidazolium cause calcium overload and oxidative stress despite reducing peak density of CaV1.2 current in ventricular myocytes | Synapse
May 11, 2026
Calmodulin inhibitors chlorpromazine and calmidazolium cause calcium overload and oxidative stress despite reducing peak density of CaV1.2 current in ventricular myocytes
Key Points
This research aims to explore how calmodulin inhibitors affect calcium dynamics and oxidative stress in heart cells.
Utilized calmodulin inhibitors chlorpromazine and calmidazolium in experiments
Measured peak density of CaV1.2 current in ventricular myocytes
Assessed levels of calcium overload and oxidative stress
Both inhibitors reduced peak density of CaV1.2 current while causing significant calcium overload.
Emergence of oxidative stress markers was observed following application of the inhibitors.
Impairments in cellular function were noted despite the reduction in CaV1.2 current density.
Abstract
Calmodulin (CaM) plays crucial roles in the regulation of the voltage-dependent L-type calcium (Ca